ArticleJournal of clinical medicine2026

LOw-Dose RAbeprazole Therapy for Reducing Gastrointestinal Events in Patients with High Bleeding Risk (LORA-HBR): A Prospective, Multicenter, Interventional Study.

Dong Oh Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.